Last reviewed · How we verify

NCT04967105

Intraoperative Renal Desaturation and Postoperative Acute Kidney Injury

Completed Last updated 11 March 2022
What this trial tests

trial testing Near-infrared spectroscopy in Postoperative Acute Kidney Injury in 157 participants. Completed in 30 January 2022.

Timeline
20 September 2020
Primary endpoint
30 October 2021
30 January 2022

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment157
Start date20 September 2020
Primary completion30 October 2021
Estimated completion30 January 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

Adults 60 to 100, any sex, with Postoperative Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the changes in renal regional oxygen saturation (rSO2) monitored by near-infrared spectroscopy (NIRS) and its relationship with the occurrence of postoperative AKI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The relationship between trajectories of renal oxygen saturation and acute kidney injury: a prospective cohort study with a secondary analysis.
    Liu C, Wang X, Shi W, Yu Y, et al · · 2024 · cited 4× · PMID 38381262 · DOI 10.1007/s40520-024-02701-1

Verify or expand the search:

Other trials of Near-infrared spectroscopy

Trials testing the same drug.

Other recruiting trials for Postoperative Acute Kidney Injury

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04967105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing